Skip to main content
. 2021 Dec 8;11:23582. doi: 10.1038/s41598-021-02900-0

Figure 1.

Figure 1

BW dosage and pharmacokinetic profile. (A) Kinetic concentration of BW in plasma and brain after a single IP injection of BW at 10 mg/kg. (B) Brain to plasma ratio of data presented on graph (A) (C) PK profile of BW after administration per os (PO), intravenous (IV) or subcutaneous (SC) in CD-1 mice. (D) Plasma and brain concentration of BW from our study animals treated with either 1 or 3 mg/kg/d.